Background: A large amount of epidemiological evidence indicates that persistent HCV infection is the main risk factor for HCC. We aimed to study the effects of persistent HCV infection on the interaction of the virus and host cell to identify cancer gene profiles. Methods: Next-generation sequencing (NGS) was used to identify differentially expressed genes between uninfected Huh7.5.1 control cells, short-term HCV (S-HCV), early long-term HCV (eL-HCV), and long-term HCV (L-HCV) infections, which were analyzed using different dynamic bioinformatics and analytic tools. mRNA expression was validated and quantified using q-PCR. One hundred ninety-six serum samples of HCV patients with IFN/RBV treatment were used to study chemokine levels. Resul...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...
Hepatotropic viruses constitute a global health concern, as the WHO estimates over 300 million peopl...
Despite the success of direct-acting antiviral (DAA) agents in treating chronic hepatitis C virus (H...
Hepatitis C virus (HCV) infection is one of the major causes of advanced liver disease and hepatocel...
Persistent infection with hepatitis C virus (HCV) is associated with an increased risk of hepatocell...
The liver is frequently exposed to toxins, metabolites, and oxidative stress, which can challenge or...
Chronic infection with hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma (HCC). N...
Hepatitis C virus (HCV) is a major cause of liver disease including metabolic disease, fibrosis, cir...
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatoc...
AbstractChronic infection by hepatitis C virus (HCV) is a major risk factor for the development of h...
Hepatitis C virus (HCV) is a major cause of liver disease including metabolic disease, fibrosis, cir...
Chronic infection with the hepatitis C virus (HCV) is a major risk factor for the development of hep...
Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepa...
Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepa...
AbstractHepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-indu...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...
Hepatotropic viruses constitute a global health concern, as the WHO estimates over 300 million peopl...
Despite the success of direct-acting antiviral (DAA) agents in treating chronic hepatitis C virus (H...
Hepatitis C virus (HCV) infection is one of the major causes of advanced liver disease and hepatocel...
Persistent infection with hepatitis C virus (HCV) is associated with an increased risk of hepatocell...
The liver is frequently exposed to toxins, metabolites, and oxidative stress, which can challenge or...
Chronic infection with hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma (HCC). N...
Hepatitis C virus (HCV) is a major cause of liver disease including metabolic disease, fibrosis, cir...
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatoc...
AbstractChronic infection by hepatitis C virus (HCV) is a major risk factor for the development of h...
Hepatitis C virus (HCV) is a major cause of liver disease including metabolic disease, fibrosis, cir...
Chronic infection with the hepatitis C virus (HCV) is a major risk factor for the development of hep...
Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepa...
Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepa...
AbstractHepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-indu...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...
Hepatotropic viruses constitute a global health concern, as the WHO estimates over 300 million peopl...
Despite the success of direct-acting antiviral (DAA) agents in treating chronic hepatitis C virus (H...